Legal Opinion
ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited
District Court, D. Delaware
Decided December 13, 2023No. 1:20-cv-00985Unknown
1Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ACADIA PHARAMCEUTICALS INC., Plaintiff, C.A. No. 20-985-GBW v. AUROBINDO PHARMA LIMITED et ai., CONSOLIDATED Defendants. MEMORANDUM ORDER . Defendants MSN Laboratories PVT. Ltd. and MSN Pharmaceuticals, Inc. (collectively, “MSN”) filed an Abbreviated New Drug Application (“ANDA”) for a generic version of the Parkinson’s drug Nuplazid®. The FDA tentatively approved MSN’s ANDA. Acadia Pharmaceuticals, Inc. (“Acadia”) asserted five patents against MSN but has voluntarily dismissed or stipulated to non-infringement of four of them.…
2Cases cited14 opinions
- Singer Manufacturing Co. v. June Manufacturing Co.Supreme Court of the United States · 1896
- Kimble v. Marvel Entertainment, LLCSupreme Court of the United States · 2015
- Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2009
- Amgen Inc. v. F. Hoffmann-La Roche Ltd.Court of Appeals for the Federal Circuit · 2009
- Pfizer, Inc. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2008
9 more not listed; retrieve them via the Exa API.